Navigation Links
Ground Breaking Findings on Understanding Cancer Published in the Current Issue of 'Science'
Date:10/5/2010

ood or also in stool samples are already available

- Extremely promising new compounds target 'M2-PK'

Cancer research is facing a radical change of direction. Cancer cells do not obtain their energy from the breakdown of sugar to carbon dioxide and water, but from energy-rich intermediates of sugar metabolism instead. This confirms the hypothesis developed by the German Noble prizewinner Otto Warburg over 80 years ago, that an altered energy production in human metabolism is characteristic of cancer. The key enzyme 'M2-PK' (PKM2) hereby plays a decisive role, as scientists from Harvard Medical School report in the current issue of the world-renowned specialist magazine 'Science'.

The results of these experiments represent a significant change in direction in the field of cancer research. They also confirm the earlier findings of scientists such as Warburg, Eigenbrodt and Mazurek that tumour cells express their own characteristic isoform of the glycolytic key enzyme pyruvate kinase. M2-PK is the synonym for both the dimeric and also the tetrameric forms of the M2 pyruvate kinase isoenzyme (also known as PKM2). The dimeric form of M2-PK is dominant in tumour cells.

A simple commercial test is already available to measure the biomarker M2-PK in stool and blood

M2-PK in stool samples can be used to screen for bowel (colorectal) cancer and in blood for monitoring therapy response and patient follow-up of various cancers. Effective and simple tests are already available for the detection of this enzyme, which have been developed and patented by the company ScheBo Biotech AG situated in Giessen, Germany, and are already marketed as commercial test kits.

Biomarker M2-PK in stool samples for the screening and early detection of bowel cancer and polyps

Clinical studies from Germany, Great Britain and Ireland, which tested M2-PK in stool samples as a metabolic marker for the early detection
'/>"/>

SOURCE ScheBo Biotech AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
2. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
3. Mitchell, Military TBI Task Force Highlight the Importance of Traumatic Brain Injury Research; Mitchell Endorses Ground Breaking Traumatic Brain Injury Study
4. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. Lake Hospital System Receives $60,000 Grant for Groundbreaking Music Therapy Study
7. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
8. Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
9. UNT Health Science Centers Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
10. Shanghai ChemPartner Is Pleased to be Part of Agios Groundbreaking Cancer Research
11. Groundbreaking Ceremony in Port-au-Prince, Haiti for FilterPure Water Filtration Factory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 UPM Pharmaceuticals, a division of ... Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout ... the first drug approved to treat hypoactive sexual desire ... dysfunction. The tablets will be manufactured at ... Tennessee . Dr. John M. ...
(Date:3/4/2015)... 4, 2015 Following the reintroduction of ... Center (LAC) released a report today urging policymakers ... and heroin epidemic through more effective use of ... "The Case for Expanding Access to Medication-Assisted Treatment ... the health, justice, and economic advantages of medication-assisted ...
(Date:3/4/2015)... 2015  Heska Corporation (Nasdaq: HSKA ) ... Join Its Fourth Quarter and Year End 2014 Earnings ... 9:00 a.m. (MST) / 11:00 a.m. (EST)Where: www.heska.com ... Call link on the front page of this website)How:Live ... web at the address above.  Alternatively, you may use ...
Breaking Medicine Technology:UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 2UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets 3Improved Medication-Assisted Treatment Policy Could Aid Epidemic of 20 Million Americans with Untreated Addiction 2Webcast Alert: Heska Announces Fourth Quarter and Year End 2014 Earnings Conference Call Webcast 2
... , MELVILLE, N.Y. , Jan. 25 ... provider of health care products and services to office-based practitioners, announced today ... and Chief Financial Officer, will present at the Jefferies 2010 Global Healthcare ... Schein,s presentation is scheduled to begin at 3:30 p.m. EST ...
... , , RYE, N.Y. , ... a drug research and development company focused on the treatment of neurological ... clinical trials for CM-AT, its autism treatment, at ten sites across the ... New York City Drexel University , Philadelphia ...
Cached Medicine Technology:Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference 2Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 2Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 3Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 4
(Date:3/4/2015)... Vancouver chiropractic clinic, Backs in Action ... the prestigious Vancouver Courier “Stars of Vancouver” 2015 ... company secured third place in the “Best Chiropractor” ... Massage Therapist” category. , As one of ... Vancouver Courier is a semiweekly local newspaper published ...
(Date:3/4/2015)... 04, 2015 " Optrix by Body ... its monthly Tech Report, which takes a look at ... to consumers. Scott Steinberg, a special reporter for NewsWatch ... shared with viewers how they have an ultra-rugged, waterproof ... industry is a major player at the Consumer Electronics ...
(Date:3/4/2015)... March 04, 2015 The Global ... billion in 2014 and is estimated to grow ... of 4.0% from 2014 to 2019. , Browse ... Market for an analysis of industry trends, segments ... global liquefied petroleum gas market is classified into ...
(Date:3/4/2015)... Organic Valley, the nation’s largest cooperative of ... cause campaign to Save the Bros, http://savethebros.com/ with ... difference to Bros everywhere. To date, the video has ... The video was named Adweek’s best commercial of the week ... Digiday, among other media outlets. , “We are pleased ...
(Date:3/4/2015)... Columbus is no stranger to drug addiction. The ... addiction, and suffers from the potential threat of Kratom. In ... DEA revealed that Kratom is a “drug of concern.” Although ... introduced herb from Southeast Asia acts as a stimulant in ... kratom foments symptoms similar to heroin withdrawal, and includes tremors, ...
Breaking Medicine News(10 mins):Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 2Health News:The Global Liquefied Petroleum Gas Market is Estimated to Reach $288.7 Billion by 2019 - A Report by MicroMarket Monitor 3Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 2Health News:ORGANIC VALLEY URGES PUBLIC TO SAVE THE BROs: CAMPAIGN EARNS MORE THAN 1M VIEWS ON YOUTUBE 3Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2
... , , IRVINE, Calif., Aug. ... share of $0.49 for the quarter ended June 30, 2009, a 24% ... The Company reported quarterly revenues of $81 million, a 4% increase compared ... , The Company,s results are reflective of improved growth ...
... an increased risk of death, found a new study of ... in CMAJ ( Canadian Medical Association Journal ) ... approximately 25% of people (both men and women) living in ... develop a spine fracture will die over a 5 year ...
... ... their already booming empire of top physicians. The much awaited International Association of Dermatologists ... their renowned directory, "The Leading Physicians Of the World". , ... New York, NY (PRWEB) August 3, 2009 ...
... , , CHICAGO, Aug. 3 Eczema ... rashes. It is commonly known as "the itch that rashes." (1) ... appears to result from a complex interaction of factors including personal and ... Scratching the affected area can lead to more itch, redness, swelling, ...
... Commentary by Betsy McCaughey ,rife with gross, cruel distortions, ... York State Director Lois Aronstein issued the following statement in response to ... reform measures passed or currently being considered by Congress. , , ... various media outlets is rife with gross -- and even cruel -- ...
... , , , ... N.C., Aug. 3 Kowa Research Institute (KRI) based in ... specialty pharmaceutical company headquartered in Montgomery, AL, announced today that ... (R) (pitavastatin), a potent HMG-CoA reductase inhibitor (statin), for ...
Cached Medicine News:Health News:CorVel Announces Revenues and Earnings 2Health News:CorVel Announces Revenues and Earnings 3Health News:CorVel Announces Revenues and Earnings 4Health News:CorVel Announces Revenues and Earnings 5Health News:Hip and back fractures increase mortality rates in people older than 50 2Health News:Top Dermatologists to be Selected and Published in "The Leading Physicians of the World" Consumer Directory. 2Health News:Five Questions About Eczema 2Health News:Five Questions About Eczema 3Health News:Five Questions About Eczema 4Health News:Five Questions About Eczema 5Health News:AARP Responds to Health Reform Scare Tactics 2Health News:AARP Responds to Health Reform Scare Tactics 3Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 2Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 3Health News:FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia 4
The Medtronic EOPA CAP® arterial cannula provides a simple solution to obtaining accurate arterial pressure readings....
Intermittent catheter...
Intermittent catheter...
... new dimension in vitreoretinal surgery. ,By ... of purified perfluoro-n-octane, you can greatly ... ideal for managing retinal detachments complicated ... and trauma. , ,Certified to be ...
Medicine Products: